Adiuvo Investment SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLADVIV00015
PLN
0.63
-0.02 (-3.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Adiuvo Investment SA stock-summary
stock-summary
Adiuvo Investment SA
Pharmaceuticals & Biotechnology
Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
Company Coordinates stock-summary
Company Details
Ul. Gen. Jozefa Zajaczka 11/14 , WARSZAWA None : 01-510
stock-summary
Tel: 48 22 408448048 22 4909401
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Krzysztof Laskowski
Independent Member of the Supervisory Board
Mr. Wojciech Bablok
Member of the Supervisory Board
Mr. Filip Elzanowski
Member of the Supervisory Board
Mr. Wojciech Napiorkowski
Member of the Supervisory Board
Mr. Pawel Nauman
Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

PLN 9 Million ()

stock-summary
P/E

3.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.76

stock-summary
Return on Equity

-4.41%

stock-summary
Price to Book

-0.25